NO990793L - 7<alfa>-(<Epsilon>-aminoalkyl)-°stratriener, fremgangsmÕte for fremstilling av disse, farmas°ytiske preparater inneholdende disse, samt deres anvendelse for fremstilling av legemidler - Google Patents

7<alfa>-(<Epsilon>-aminoalkyl)-°stratriener, fremgangsmÕte for fremstilling av disse, farmas°ytiske preparater inneholdende disse, samt deres anvendelse for fremstilling av legemidler

Info

Publication number: NO990793L
Authority: NO; Norway
Prior art keywords: pharmaceuticals; stratrienes; alfa; epsilon; aminoalkyl
Prior art date: 1996-08-20

Application number

NO990793A

Other languages

English (en)

Other versions

NO315655B1 (no

NO990793D0 (no

Inventor

Rolf Bohlmann

Dieter Bittler

Josef Heindi

Nikolaus Heinrich

Helmut Hofmeister

Hermann Kuenzer

Gerhard Sauer

Christa Hegele-Hartung

Rosemarie Lichtner

Yukishige Nishino

Karsten Parczyk

Martin Schneider

Original Assignee

Schering Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-08-20

Filing date

1999-02-19

Publication date

1999-04-20

1999-02-19 Application filed by Schering Ag filed Critical Schering Ag

1999-02-19 Publication of NO990793D0 publication Critical patent/NO990793D0/no

1999-04-20 Publication of NO990793L publication Critical patent/NO990793L/no

2003-10-06 Publication of NO315655B1 publication Critical patent/NO315655B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
- C07J53/002—Carbocyclic rings fused
- C07J53/004—3 membered carbocyclic rings
- C07J53/008—3 membered carbocyclic rings in position 15/16
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/32—Antioestrogens
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0072—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the A ring of the steroid being aromatic
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/006—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton spiro-condensed
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
- C07J53/002—Carbocyclic rings fused

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Steroid Compounds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO19990793A 1996-08-20 1999-02-19 7<alfa>-(<Epsilon>-aminoalkyl)-östratriener, farmasöytiske preparater inneholdende disse, samt deres anvendelse for fremstilling avlegemidler NO315655B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE19635525A DE19635525A1 (de)	1996-08-20	1996-08-20	7alpha-(xi-Aminoalkyl)-estratriene, Verfahren zu deren Herstellung, pharmazeutische Präparate, die diese 7alpha(xi-Aminoalkyl-estratriene enthalten sowie deren Verwendung zur Herstellung von Arzneimitteln
PCT/EP1997/004517 WO1998007740A1 (de)	1996-08-20	1997-08-20	7α-(κ-AMINOALKYL)-ESTRATRIENE, VERFAHREN ZU DEREN HERSTELLUNG, PHARMAZEUTISCHE PRÄPARATE, DIE DIESE 7α-(κ-AMINOALKYL)-ESTRATRIENE ENTHALTEN SOWIE DEREN VERWENDUNG ZUR HERSTELLUNG VON ARZNEIMITTELN

Publications (3)

Publication Number	Publication Date
NO990793D0 NO990793D0 (no)	1999-02-19
NO990793L true NO990793L (no)	1999-04-20
NO315655B1 NO315655B1 (no)	2003-10-06

Family

ID=7804367

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19990793A NO315655B1 (no)	1996-08-20	1999-02-19	7<alfa>-(<Epsilon>-aminoalkyl)-östratriener, farmasöytiske preparater inneholdende disse, samt deres anvendelse for fremstilling avlegemidler

Country Status (29)

Country	Link
EP (1)	EP0920441B1 (no)
JP (1)	JP2001503024A (no)
KR (1)	KR20000068261A (no)
CN (1)	CN1231670A (no)
AR (1)	AR009278A1 (no)
AT (1)	ATE231882T1 (no)
AU (1)	AU728843B2 (no)
BG (1)	BG62972B1 (no)
BR (1)	BR9711328A (no)
CA (1)	CA2263708A1 (no)
CZ (1)	CZ57999A3 (no)
DE (2)	DE19635525A1 (no)
DK (1)	DK0920441T3 (no)
EA (1)	EA001577B1 (no)
EE (1)	EE04021B1 (no)
ES (1)	ES2191857T3 (no)
HU (1)	HUP9903106A3 (no)
IL (1)	IL128601A (no)
IS (1)	IS4976A (no)
NO (1)	NO315655B1 (no)
NZ (1)	NZ334277A (no)
PL (1)	PL186309B1 (no)
PT (1)	PT920441E (no)
SK (1)	SK18899A3 (no)
TR (1)	TR199900432T2 (no)
TW (1)	TW552267B (no)
UA (1)	UA50792C2 (no)
WO (1)	WO1998007740A1 (no)
ZA (1)	ZA977482B (no)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PE20000129A1 (es) *	1997-12-23	2000-03-11	Schering Ag	11 beta-halogeno-estratrienos sustituidos en 7 alfa, asi como el procedimiento para elaborar preparados farmaceuticos que contienen tales 11 beta-halogeno-estratrienos sustituidos en 7 alfa
US6548491B2 (en)	1997-12-24	2003-04-15	Sri International	Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
US6054446A (en)	1997-12-24	2000-04-25	Sri International	Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
US6503896B1 (en)	1997-12-24	2003-01-07	Sri International	Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
DE19807791A1 (de) *	1998-02-19	1999-08-26	Schering Ag	Kombinationspräparat aus Östrogen und Antiöstrogen
DE19833786A1 (de) *	1998-07-18	2000-01-20	Schering Ag	Benzocycloheptene, Verfahren zu ihrer Herstellung, pharmazeutische Präparate, die diese enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln
DE19842123C1 (de) *	1998-09-05	2000-07-13	Schering Ag	11beta-Fluor-7alpha-(14,14,15,15,15-pentafluor-6- methyl-10-thia-6-azapentadecyl)estra-1,3,5(10)- trien-3,17beta-diol als kristallines Ansolvat
DE19906159A1 (de) *	1999-02-09	2000-08-10	Schering Ag	16-Hydroxyestratriene als selektiv wirksame Estrogene
AU6913700A (en) *	1999-08-18	2001-03-13	Schering Aktiengesellschaft	Piperidine and pyrrolidine derivatives displaying neuronal activity
GB0000313D0 (en) *	2000-01-10	2000-03-01	Astrazeneca Uk Ltd	Formulation
DE10019171A1 (de) *	2000-04-07	2001-10-18	Schering Ag	Zusammensetzungen zur Verwendung als Penetrationsverstärker in transdermalen Formulierungen für hoch lipophile Wirkstoffe
DE10159217A1 (de) *	2001-11-27	2003-06-05	Schering Ag	17alpha-Alkyl-17ß-oxy-estratriene und Zwischenprodukte zu deren Herstellung, Verwendung der 17alpha-Alkyl-17ß-oxy-estratriene zur Herstellung von Arzneimitteln sowie pharmazeutische Präparate
AU2006202187B2 (en) *	2001-11-27	2008-11-06	Bayer Schering Pharma Aktiengesellschaft	17alpah-alkyl-17beta-oxy-estratrienes and intermediate products for their production, uses thereof and pharmaceutical preparations
US20040242551A1 (en) *	2003-05-28	2004-12-02	Schering Ag	Composition comprising antiprogestins and pure antiestrogens for prophylaxis and treatment of hormone-dependent diseases
DE602005023877D1 (de)	2004-07-27	2010-11-11	Sicor Inc	Verfahren zur herstellung von 7-alpha-alkylierte 19-norsteroide
BRPI0618755A2 (pt)	2005-11-22	2011-09-13	Sumitomo Chemical Co	compostos de enxofre orgánicos e uso destes
DE102007049630A1 (de)	2007-10-11	2009-10-29	Bayer Schering Pharma Aktiengesellschaft	Nichtsteroidale Progesteronrezeptor-Modulatoren
DE102007023614A1 (de)	2007-05-21	2008-11-27	Bayer Schering Pharma Aktiengesellschaft	Nichtsteroidale Progesteronrezeptor-Modulatoren
TW200904329A (en)	2007-05-18	2009-02-01	Sumitomo Chemical Co	Organic sulfur compound and its use for controlling harmful arthropod
JP2009001551A (ja)	2007-05-18	2009-01-08	Sumitomo Chemical Co Ltd	有機硫黄化合物及びその有害節足動物防除用途
JP5298631B2 (ja)	2007-05-18	2013-09-25	住友化学株式会社	有機硫黄化合物及びその有害節足動物防除用途
DE102007032800A1 (de)	2007-07-10	2009-01-15	Bayer Schering Pharma Aktiengesellschaft	Nichtsteroidale Progesteronrezeptor-Modulatoren
NZ591955A (en)	2007-10-16	2011-10-28	Repros Therapeutics Inc	Trans-clomiphene for diabetes mellitus type 2
DE102007058747A1 (de)	2007-12-05	2009-06-10	Bayer Schering Pharma Aktiengesellschaft	Nichtsteroidale Progesteronrezeptor-Modulatoren
EP2070909A1 (de)	2007-12-15	2009-06-17	Bayer Schering Pharma AG	Nichtsteroidale Progesteronrezeptor-Modulatoren
EP2070941A1 (en)	2007-12-14	2009-06-17	Bayer Schering Pharma Aktiengesellschaft	Stereoselective synthesis of selective estrogen receptor down-regulators
DE102008057230A1 (de)	2008-11-11	2010-05-12	Bayer Schering Pharma Aktiengesellschaft	Synergistische pharmazeutische Kombination mit einem Estrogenrezeptorantagonisten und einem Progestin
JP5212350B2 (ja)	2008-12-24	2013-06-19	住友化学株式会社	含ハロゲン有機硫黄化合物およびその用途
EP2258375A1 (de)	2009-06-04	2010-12-08	Bayer Schering Pharma Aktiengesellschaft	17B-alkyl-17alpha-oxy-estratriene
DE102009034367A1 (de)	2009-07-20	2011-01-27	Bayer Schering Pharma Aktiengesellschaft	17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-benzyliden-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
DE102009034362A1 (de)	2009-07-20	2011-01-27	Bayer Schering Pharma Aktiengesellschaft	17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034368A1 (de)	2009-07-20	2011-01-27	Bayer Schering Pharma Aktiengesellschaft	17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-acyloxyalkylenphenyl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034366A1 (de)	2009-07-20	2011-01-27	Bayer Schering Pharma Aktiengesellschaft	17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-methylenoxyalkylenaryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
DE102009034526A1 (de)	2009-07-21	2011-02-10	Bayer Schering Pharma Aktiengesellschaft	17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-ethinylphenyl-Derivate, Verfahren zu deren Herstellung und deren Verwendung zur Behandlung von Krankheiten
DE102009034525A1 (de)	2009-07-21	2011-01-27	Bayer Schering Pharma Aktiengesellschaft	17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
WO2011092127A1 (en)	2010-01-26	2011-08-04	Bayer Schering Pharma Aktiengesellschaft	14,17-bridged estratriene derivatives comprising heterocyclic bioisosteres for the phenolic a-ring
DE102010007722A1 (de)	2010-02-10	2011-08-11	Bayer Schering Pharma Aktiengesellschaft, 13353	Progesteronrezeptorantagonisten
DE102010007719A1 (de)	2010-02-10	2011-08-11	Bayer Schering Pharma Aktiengesellschaft, 13353	Progesteronrezeptorantagonisten
KR20190042762A (ko)	2010-06-16	2019-04-24	앙도르쉐르슈 인코포레이티드	에스트로겐-관련 질병의 치료 또는 예방 방법
DE102010030538A1 (de)	2010-06-25	2011-12-29	Bayer Schering Pharma Aktiengesellschaft	6,7-Dihydro-5H-benzo[7]annulen-Derivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate die diese enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln
DE102011004899A1 (de)	2011-03-01	2012-09-06	Bayer Pharma Aktiengesellschaft	17-Hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Behandlung von Krankheiten
LT2753632T (lt)	2011-09-08	2023-07-10	Sage Therapeutics, Inc.	Neuroaktyvieji steroidai, jų kompozicijos ir naudojimas
DE102011087987A1 (de)	2011-12-08	2013-06-13	Bayer Intellectual Property Gmbh	6,7-Dihydro-5H-benzo[7]annulen-Derivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate die diese enthalten, sowie deren Verwendung zur Herstellung von Arzneimitteln
CA2865234A1 (en)	2012-02-29	2013-09-06	Repros Therapeutics Inc.	Combination therapy for treating androgen deficiency
SMT202100475T1 (it)	2013-03-13	2021-09-14	Sage Therapeutics Inc	Steroidi neuroattivi
BR112015025706A2 (pt)	2013-04-11	2017-07-18	Bayer Pharma AG	forma de dosagem do antagonista do receptor de progesterona
US20160060288A1 (en) *	2013-04-18	2016-03-03	Xi'anlibang Pharmaceutical Technology Co., Ltd.	Ester derivatives of 7-alpha-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl)-estra-1,3,5(10)-triene-3,17beta-diol having anticancer activity and preparation method thereof
ES2970222T3 (es)	2014-06-18	2024-05-27	Sage Therapeutics Inc	Oxiesteroles y procedimientos de uso de los mismos
AU2016352592B2 (en)	2015-11-10	2023-04-27	Paracrine Therapeutics Ab	Treatment of ER-negative breast cancer with an PDGF-CC inhibitor and an anti estrogen
HRP20220716T1 (hr)	2016-04-01	2022-09-02	Sage Therapeutics, Inc.	Oksisteroli i postupci za njihovu uporabu
WO2017193046A1 (en)	2016-05-06	2017-11-09	Sage Therapeutics, Inc.	Oxysterols and methods of use thereof
MD3481846T2 (ro)	2016-07-07	2021-11-30	Sage Therapeutics Inc	24-Hidroxisteroli 11-substituiți pentru utilizare în tratamentul stărilor legate de NMDA
US11149056B2 (en)	2016-09-30	2021-10-19	Sage Therapeutics, Inc.	C7 substituted oxysterols and methods of use thereof
KR20230051723A (ko)	2016-10-18	2023-04-18	세이지 테라퓨틱스, 인크.	옥시스테롤 및 그의 사용 방법
CN115505019B (zh) *	2022-11-07	2024-01-26	南宁师范大学	7-酰胺取代雌甾类化合物及其制备方法和应用
CN116041412A (zh) *	2023-01-13	2023-05-02	香港中文大学（深圳）	氟维司群衍生物及其制备方法、应用和治疗乳腺癌的药物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8327256D0 (en) *	1983-10-12	1983-11-16	Ici Plc	Steroid derivatives
HU208150B (en) *	1988-10-31	1993-08-30	Endorecherche Inc	Process for producing new estrogen derivatives having steroid hormone inhibitor activity and pharmaceutical compositions comprising such derivatives
DE3925507A1 (de) *	1989-07-28	1991-01-31	Schering Ag	14,17(alpha)-etheno- und ethanoestratriene, verfahren zur herstellung dieser verbindungen, sowie ihre verwendung zur herstellung von arzneimitteln
DE4218743C2 (de) *	1992-06-04	2001-10-25	Schering Ag	Verfahren zur Herstellung C(7)-substituierter Estra-1,3,5(10)-triene sowie neue Ausgangsprodukte für dieses Verfahren

1996
- 1996-08-20 DE DE19635525A patent/DE19635525A1/de not_active Withdrawn
1997
- 1997-08-20 UA UA99031552A patent/UA50792C2/uk unknown
- 1997-08-20 KR KR1019997001396A patent/KR20000068261A/ko not_active Application Discontinuation
- 1997-08-20 SK SK188-99A patent/SK18899A3/sk unknown
- 1997-08-20 JP JP10510412A patent/JP2001503024A/ja not_active Ceased
- 1997-08-20 HU HU9903106A patent/HUP9903106A3/hu unknown
- 1997-08-20 CA CA002263708A patent/CA2263708A1/en not_active Abandoned
- 1997-08-20 TR TR1999/00432T patent/TR199900432T2/xx unknown
- 1997-08-20 DE DE59709239T patent/DE59709239D1/de not_active Expired - Fee Related
- 1997-08-20 TW TW086111927A patent/TW552267B/zh active
- 1997-08-20 DK DK97943814T patent/DK0920441T3/da active
- 1997-08-20 ZA ZA9707482A patent/ZA977482B/xx unknown
- 1997-08-20 WO PCT/EP1997/004517 patent/WO1998007740A1/de not_active Application Discontinuation
- 1997-08-20 ES ES97943814T patent/ES2191857T3/es not_active Expired - Lifetime
- 1997-08-20 EP EP97943814A patent/EP0920441B1/de not_active Expired - Lifetime
- 1997-08-20 CN CN97198245A patent/CN1231670A/zh active Pending
- 1997-08-20 AR ARP970103779A patent/AR009278A1/es not_active Application Discontinuation
- 1997-08-20 PL PL97331863A patent/PL186309B1/pl not_active IP Right Cessation
- 1997-08-20 AU AU45520/97A patent/AU728843B2/en not_active Ceased
- 1997-08-20 PT PT97943814T patent/PT920441E/pt unknown
- 1997-08-20 BR BR9711328A patent/BR9711328A/pt unknown
- 1997-08-20 EE EEP199900075A patent/EE04021B1/xx not_active IP Right Cessation
- 1997-08-20 AT AT97943814T patent/ATE231882T1/de not_active IP Right Cessation
- 1997-08-20 EA EA199900210A patent/EA001577B1/ru not_active IP Right Cessation
- 1997-08-20 CZ CZ99579A patent/CZ57999A3/cs unknown
- 1997-08-20 IL IL12860197A patent/IL128601A/xx not_active IP Right Cessation
- 1997-08-20 NZ NZ334277A patent/NZ334277A/xx unknown
1999
- 1999-02-11 IS IS4976A patent/IS4976A/is unknown
- 1999-02-16 BG BG103185A patent/BG62972B1/bg unknown
- 1999-02-19 NO NO19990793A patent/NO315655B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
IL128601A (en)	2003-07-31
EE9900075A (et)	1999-10-15
UA50792C2 (uk)	2002-11-15
AU728843B2 (en)	2001-01-18
TW552267B (en)	2003-09-11
ES2191857T3 (es)	2003-09-16
DE59709239D1 (de)	2003-03-06
BG62972B1 (bg)	2000-12-29
TR199900432T2 (xx)	1999-04-21
NZ334277A (en)	2000-10-27
ATE231882T1 (de)	2003-02-15
DE19635525A1 (de)	1998-02-26
PT920441E (pt)	2003-06-30
NO315655B1 (no)	2003-10-06
CZ57999A3 (cs)	1999-08-11
DK0920441T3 (da)	2003-05-26
IS4976A (is)	1999-02-11
SK18899A3 (en)	1999-08-06
KR20000068261A (ko)	2000-11-25
HUP9903106A2 (hu)	2000-03-28
HUP9903106A3 (en)	2000-05-29
PL186309B1 (pl)	2003-12-31
CN1231670A (zh)	1999-10-13
EA001577B1 (ru)	2001-06-25
EA199900210A1 (ru)	1999-08-26
JP2001503024A (ja)	2001-03-06
IL128601A0 (en)	2000-01-31
CA2263708A1 (en)	1998-02-26
ZA977482B (en)	1998-02-23
WO1998007740A1 (de)	1998-02-26
AU4552097A (en)	1998-03-06
AR009278A1 (es)	2000-04-12
EE04021B1 (et)	2003-04-15
BR9711328A (pt)	1999-08-17
EP0920441B1 (de)	2003-01-29
NO990793D0 (no)	1999-02-19
EP0920441A1 (de)	1999-06-09
BG103185A (en)	1999-11-30
PL331863A1 (en)	1999-08-16

Publication	Publication Date	Title
NO990793L (no)	1999-04-20	7<alfa>-(<Epsilon>-aminoalkyl)-°stratriener, fremgangsmÕte for fremstilling av disse, farmas°ytiske preparater inneholdende disse, samt deres anvendelse for fremstilling av legemidler
NO304488B1 (no)	1998-12-28	5-leddede heteroaryloksazolidinoner, anvendelse av disse for fremstilling av legemidler samt legemiddel inneholdende forbindelsen
NO984852L (no)	1998-11-16	Nye benzazepinderivater, medikamenter inneholdende forbindelsene samt deres anvendelse ved fremstilling av medikamentene
HUP0102187A3 (en)	2002-12-28	Azolo triazines and pyrimidines, pharmaceutical compositions containing them and use of the compounds
DE69415163D1 (de)	1999-01-21	ZUZAMMENSETUNG ENTHALTEND 1,1,1,2,3,4,4,5,5,5,-DECAFLUORPENTAN UND n-PROPANOL
NO20021714L (no)	2000-05-11	2-fenyl-substituerte imidazotriazinoner, fremgangsmåte for fremstilling derav samt anvendelse av forbindelsene
NO984082L (no)	1998-09-04	Pyrimido[5,4-d]pyrimidiner, medikamenter inneholdende disse forbindelser, deres anvendelse og fremgangsmÕte for fremstilling derav
NO923466D0 (no)	1992-09-04	Heterocykliske forbindelser med 5 ledd, fremgangsmaate forfremstilling, samt legemidler som inneholder disse forbindelser
AP9400654A0 (en)	1994-07-31	Novel imidazole compounds, processes for the preparation thereof and their use in therapay
EE9700031A (et)	1997-08-15	Pürido-liitunud tienüül- ja furanüüloksasolidinoonid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid
NO20010013L (no)	2001-03-01	Svovelsubstituerte sulfonylaminokarboksylsyre N-arylamider, deres fremstilling og anvendelse samt farmasöytiske preparater inneholdende forbindelsene
EE9700044A (et)	1997-08-15	Heteroarüüloksasolidinoonid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid.
AU3813499A (en)	1999-11-08	The use of dihydropyrimidines as medicaments, and novel substances
NO169446C (no)	1992-06-24	Fremgangsmaate for fremstilling av stive polyuretanskum, samt forloepermateriale for anvendelse ved fremgangsmaaten
ID23421A (id)	2000-04-20	Turunan 3-tersubstitusi 3,4-dihidrotieno[2,3-d]pirimidin, pembuatan dan penggunaannya
NO308287B1 (no)	2000-08-28	Substituerte 4-fenyl-6-amino-nikotinsyrederivater, legemidler inneholdende disse samt deres anvendelse
ZA941993B (en)	1994-09-23	Amidine derivatives containing heterocyclic groups the preparation and use thereof
ID17076A (id)	1997-12-04	Turunan 2,4-disubstitusi pirimidin, proses untuk pembuatan zat yang sama dan komposisi farmasi yang mengandung zat yang sama
ZA952410B (en)	1995-12-01	Substituted heterocyclic carboxamioesters their preparation and their use as pharmaceuticals
NO306060B1 (no)	1999-09-13	Substituerte kanelsyreguanidider, deres anvendelse samt medikamenter inneholdende guanididene
NO960529D0 (no)	1996-02-09	Substituerte benzensulfonylureaer og -tioureaer, fremgangsmåte for fremstilling av disse, og deres anvendelse for fremstilling av farmasöytiske preparater samt farmasöytiske preparater inneholdende forbindelsene
ID24222A (id)	2000-07-13	TURUNAN-TURUNAN 3-TERSUBSTITUSI 3,4,5,7-TETRAHIDROPIROLO [3',4':4,5] TIENO- [2,3-d] PIRIMIDIN, PEMBUATAN DAN PENGGUNAANNYA
HUP0105111A3 (en)	2003-02-28	2,5-substituted benzolsulfonylureas and thioureas, methods for the production thereof, use thereof and pharmaceutical preparations containing the same
ID23156A (id)	2000-03-23	Turunan-turunan amidina, proses pembuatan komposisi dan penggunaannya
NO308528B1 (no)	2000-09-25	Substituerte 1-naftoylguanidiner, deres anvendelse for fremstilling av medikamenter samt helbredende middel inneholdende forbindelsene

Legal Events

Date	Code	Title	Description
2005-05-02	MM1K	Lapsed by not paying the annual fees